CSS
SCPH

Cubist Systematic Strategies’s scPharmaceuticals SCPH Stock Holding History

Cubist Systematic Strategies’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$150K Buy
+26,532
New +$136K ﹤0.01% 2715
2025
Q2 		– Sell
-28,759
Closed -$75.6K – 3784
2025
Q1 		$75.6K Buy
+28,759
New +$93.7K ﹤0.01% 2665
2023
Q2 		– Sell
-91,453
Closed -$829K – 4245
2023
Q1 		$829K Buy
91,453
+39,661
+77% +$291K 0.01% 2328
2022
Q4 		$371K Buy
51,792
+40,219
+348% +$246K ﹤0.01% 3223
2022
Q3 		$75K Buy
+11,573
New +$61.8K ﹤0.01% 4070

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $168B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return